OTCMKTS:ARTH - Arch Therapeutics SEC Filings & 10K Form

$0.2592
-0.01 (-3.71 %)
(As of 09/18/2019 01:48 PM ET)
Today's Range
$0.2550
Now: $0.2592
$0.27
50-Day Range
$0.26
MA: $0.28
$0.30
52-Week Range
$0.25
Now: $0.2592
$0.62
Volume213,562 shs
Average Volume220,624 shs
Market Capitalization$44.73 million
P/E RatioN/A
Dividend YieldN/A
Beta0.13

SEC Filings

Arch Therapeutics (OTCMKTS:ARTH) SEC Filings

DateFilerForm TypeView
08/07/2019
7:23 AM
Arch Therapeutics (Filer)
Form 424B3
08/07/2019
7:19 AM
Arch Therapeutics (Filer)
Form 424B3
08/05/2019
7:02 AM
Arch Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2019
3:14 PM
Arch Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2019
3:10 PM
Arch Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/13/2019
7:04 AM
Arch Therapeutics (Filer)
Form 424B5
05/13/2019
6:59 AM
Arch Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2019
6:59 AM
Arch Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2019
1:56 PM
Arch Therapeutics (Subject)
Parker Michael Andrew (Filed by)
Form SC 13G/A
02/01/2019
9:38 AM
Arch Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
12/19/2018
6:33 AM
Arch Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
12/18/2018
3:17 PM
Arch Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
12/17/2018
7:07 AM
Arch Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2018
6:57 AM
Arch Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2018
6:53 AM
Arch Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/28/2018
7:00 AM
Arch Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2018
8:05 AM
Arch Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2018
11:00 PM
Arch Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2018
6:55 AM
Arch Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2018
11:41 AM
Arch Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/20/2018
12:13 PM
Arch Therapeutics (Issuer)
DHILLON AVTAR S (Reporting)
Form 4/A
07/20/2018
11:05 AM
Arch Therapeutics (Issuer)
SULAT JAMES R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/20/2018
11:04 AM
Arch Therapeutics (Issuer)
Norchi Terrence W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/20/2018
11:04 AM
Arch Therapeutics (Issuer)
DAVIS RICHARD E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/20/2018
11:03 AM
Arch Therapeutics (Issuer)
DHILLON PUNIT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/20/2018
11:00 AM
Arch Therapeutics (Issuer)
DHILLON AVTAR S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/20/2018
10:43 AM
Arch Therapeutics (Issuer)
DHILLON PUNIT (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/20/2018
6:38 AM
Arch Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2018
1:33 PM
Arch Therapeutics (Issuer)
SULAT JAMES R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2018
7:22 AM
Arch Therapeutics (Filer)
Form 424B5
06/29/2018
7:16 AM
Arch Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2018
6:55 AM
Arch Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/15/2018
7:05 AM
Arch Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2018
6:56 AM
Arch Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2018
3:06 PM
Arch Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
03/12/2018
3:41 PM
Arch Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2018
2:14 PM
Arch Therapeutics (Subject)
Parker Michael Andrew (Filed by)
Form SC 13G/A
02/05/2018
7:05 AM
Arch Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/01/2018
3:09 PM
Arch Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
12/18/2017
6:55 AM
Arch Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 9/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel